Literature DB >> 37376

Proliferative capacity of erythropoietic stem cell lines and aging: an overview.

D E Harrison.   

Abstract

The earliest bone marrow precursor cell types, often called stem CELLS, have a very large capacity for self renewal. This makes them a useful model system in which to test the hypothesis that normal somatic cells have a limited proliferative capacity. Marrow precursor cells differentiate and multiply to replenish the supply of various blood cell types that constantly turn over. Especially with erythrocyte production, this function is well difined and can be tested rigorously to determine whether a significant amount of the stem cell proliferative capacity is exhausted. Functional tests generally show that marrow stem cell lines are exhausted after three to six serial transplantations into successive recipients; the few exceptions are cases in which functioning by cells from the irradiated recipients has not been ruled out. Genetic markers unambiguously identifying marrow stem cell lines from the original donor are necessary for clear cut interpretations of transplantation experiments. No significant differences are found when comparing erythrocyte production by marrow stem cell lines from old and young adult donors. This suggests that little or none of the erythropoietic stem cell's proliferative capacity is exhausted by a lifespan of normal functioning.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 37376     DOI: 10.1016/0047-6374(79)90082-4

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  12 in total

1.  Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways.

Authors:  Anna V Molofsky; Shenghui He; Mohammad Bydon; Sean J Morrison; Ricardo Pardal
Journal:  Genes Dev       Date:  2005-06-15       Impact factor: 11.361

Review 2.  Emerging models and paradigms for stem cell ageing.

Authors:  D Leanne Jones; Thomas A Rando
Journal:  Nat Cell Biol       Date:  2011-05       Impact factor: 28.824

3.  Hematopoietic stem cell exhaustion impacted by p18 INK4C and p21 Cip1/Waf1 in opposite manners.

Authors:  Hui Yu; Youzhong Yuan; Hongmei Shen; Tao Cheng
Journal:  Blood       Date:  2005-10-18       Impact factor: 22.113

Review 4.  The Achilles' heel of cancer survivors: fundamentals of accelerated cellular senescence.

Authors:  Shameel Shafqat; Evelyn Arana Chicas; Areez Shafqat; Shahrukh K Hashmi
Journal:  J Clin Invest       Date:  2022-07-01       Impact factor: 19.456

5.  In vivo biocompatibility study of electrospun chitosan microfiber for tissue engineering.

Authors:  Yun Mi Kang; Bit Na Lee; Jae Hoon Ko; Gyeong Hae Kim; Kkot Nim Kang; Da Yeon Kim; Jae Ho Kim; Young Hwan Park; Heung Jae Chun; Chun Ho Kim; Moon Suk Kim
Journal:  Int J Mol Sci       Date:  2010-10-25       Impact factor: 5.923

Review 6.  Sirtuin 1, stem cells, aging, and stem cell aging.

Authors:  Charlie Mantel; Hal E Broxmeyer
Journal:  Curr Opin Hematol       Date:  2008-07       Impact factor: 3.284

7.  Loss of stem cell repopulating ability upon transplantation. Effects of donor age, cell number, and transplantation procedure.

Authors:  D E Harrison; C M Astle
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

8.  Long-term erythropoietic repopulating ability of old, young, and fetal stem cells.

Authors:  D E Harrison
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

9.  Chemotherapy and Stem Cell Transplantation Increase p16INK4a Expression, a Biomarker of T-cell Aging.

Authors:  William A Wood; Janakiraman Krishnamurthy; Natalia Mitin; Chad Torrice; Joel S Parker; Anna C Snavely; Thomas C Shea; Jonathan S Serody; Norman E Sharpless
Journal:  EBioMedicine       Date:  2016-08-21       Impact factor: 8.143

Review 10.  Amyotrophic lateral sclerosis as a protein level, non-genomic disease: Therapy with S2RM exosome released molecules.

Authors:  Greg Maguire
Journal:  World J Stem Cells       Date:  2017-11-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.